Original Literature | Model OverView |
---|---|
Publication
Title
G-protein-coupled receptor expression, function, and signaling in macrophages.
Affiliation
Cooperative Research Centre for Chronic Inflammatory Diseases, University ofQueensland, St. Lucia, Brisbane, QLD 4072, Australia.
Abstract
G-protein-coupled receptors (GPCRs) are widely targeted in drug discovery. Asmacrophages are key cellular mediators of acute and chronic inflammation, wereview here the role of GPCRs in regulating macrophage function, with a focus oncontribution to disease pathology and potential therapeutic applications. Withinthis analysis, we highlight novel GPCRs with a macrophage-restricted expressionprofile, which provide avenues for further exploration. We also review anemerging literature, which documents novel roles for GPCR signaling componentsin GPCR-independent signaling in macrophages. In particular, we examine thecrosstalk between GPCR and TLR signaling pathways and highlight GPCR signalingmolecules which are likely to have uncharacterized functions in this celllineage.
PMID
17456803
|
Entity
Process
IL-6
--
G010262
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93248
10
infinite
0
TRANSFAC | G010262 |
--
IL-1beta
--
G010389
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93364
10
infinite
0
TRANSFAC | G010389 |
--
ERK
--
MO000000011
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m179
10
infinite
0
--
p38{active}
--
MO000000022
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m120
10
infinite
0
TRANSPATH | MO000000022 |
--
csml-variable:Double
m217
10
infinite
0
--
csml-variable:Double
m181
10
infinite
0
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m129
10
infinite
0
TRANSPATH | MO000000058 |
--
TNF
--
MO000000204
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m175
10
infinite
0
TRANSPATH | MO000000204 |
--
IL-1
--
MO000000214
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m185
10
infinite
0
TRANSPATH | MO000000214 |
--
Class A GPCR
--
MO000000314
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m249
10
infinite
0
TRANSPATH | MO000000314 |
--
ERK1
--
MO000004670
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m549
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004670 |
--
ERK2
--
MO000004676
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m554
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004676 |
--
IL-6
--
MO000007384
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m871
10
infinite
0
InterPro | IPR003573 |
TRANSPATH | MO000007384 |
--
STAT1
--
MO000013119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1357
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
PAR1 precursor
--
MO000013668
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1420
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000013668 |
--
IL-1alpha
--
MO000016589
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1584
10
infinite
0
InterPro | IPR008996 |
TRANSPATH | MO000016589 |
--
IL-1beta
--
MO000016597
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1591
10
infinite
0
TRANSPATH | MO000016597 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
thrombin
--
MO000017008
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1909
10
infinite
0
InterPro | IPR009003 |
TRANSPATH | MO000017008 |
--
PAR2 precursor
--
MO000017020
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1920
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000017020 |
--
GRK
--
MO000017069
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1961
10
infinite
0
TRANSPATH | MO000017069 |
--
beta-arrestin
--
MO000017072
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1964
10
infinite
0
TRANSPATH | MO000017072 |
--
beta-arrestin1
--
MO000017073
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1965
10
infinite
0
InterPro | IPR000698 |
TRANSPATH | MO000017073 |
--
beta-arrestin2
--
MO000017074
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1966
10
infinite
0
InterPro | IPR000698 |
TRANSPATH | MO000017074 |
--
GRK2
--
MO000017093
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1984
10
infinite
0
--
CXCR4
--
MO000017157
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2033
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000017157 |
--
IL-10
--
MO000017247
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2103
10
infinite
0
InterPro | IPR000098 |
TRANSPATH | MO000017247 |
--
IL-8
--
MO000017264
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2120
10
infinite
0
InterPro | IPR002473 |
TRANSPATH | MO000017264 |
--
MCP-1
--
MO000017280
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2133
10
infinite
0
InterPro | IPR008097 |
TRANSPATH | MO000017280 |
--
CCR5
--
MO000017281
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2134
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000017281 |
--
PAR2{active}
--
MO000017394
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2226
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000017394 |
--
JNK3
--
MO000017818
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2570
10
infinite
0
--
PAR1{active}
--
MO000018417
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3055
10
infinite
0
InterPro | IPR000276 |
TRANSPATH | MO000018417 |
--
NADPH oxidase
--
MO000021432
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m5783
10
infinite
0
TRANSPATH | MO000021432 |
--
FPRL1
--
MO000063316
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m38196
10
infinite
0
TRANSPATH | MO000063316 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LTB4:LTB4R2
--
e100
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m101
0
infinite
0
--
NADPH oxidase{active}
--
e101
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m102
10
infinite
0
TRANSPATH | MO000021432 |
--
IL-12
--
e102
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m103
0
infinite
0
--
IL-10
--
e103
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m104
0
infinite
0
--
IP-10
--
e104
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m105
0
infinite
0
--
CCL22
--
e105
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m106
0
infinite
0
--
CCL22
--
e106
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m107
0
infinite
0
--
CCR4:CCL22
--
e107
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m108
0
infinite
0
--
EMR2
--
e108
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m109
0
infinite
0
--
EMR1
--
e109
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m110
0
infinite
0
--
GDP: alpha Gprotein
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
Chondroitin sulfate
--
e110
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m111
0
infinite
0
--
CD97:Chondroitin sulfate
--
e111
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m112
0
infinite
0
--
EMR2:Chondroitin sulfate
--
e112
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m113
0
infinite
0
--
proteoglycan
--
e113
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m114
0
infinite
0
--
EMR1:Proteoglycan
--
e114
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m115
0
infinite
0
--
PTx
--
e115
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m116
0
infinite
0
--
Galpha i2
--
e116
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m117
0
infinite
0
--
Galpha i2{p}
--
e117
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m118
0
infinite
0
--
Beta-gamma: GDP:alpha Gprotein
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
ERK1{active}
--
e120
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m122
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004670 |
--
ERK2{active}
--
e121
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m123
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004676 |
--
Galpha i1
--
e123
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m125
0
infinite
0
--
Galpha i3
--
e124
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m126
0
infinite
0
--
Thromnaxane B2 protein
--
e125
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m127
0
infinite
0
--
Thrombaxane B2
--
e126
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m128
0
infinite
0
--
NF-kappaB{active}
--
e127
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m130
10
infinite
0
TRANSPATH | MO000000058 |
--
C3a:C3aR
--
e128
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m131
0
infinite
0
--
Ligand:CXCR2
--
e129
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m132
0
infinite
0
--
Class A GPCR: Chemokine
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
Ligand:FPR
--
e130
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m133
0
infinite
0
--
IL-8:IL-8R
--
e131
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m134
0
infinite
0
--
GBeta2L1
--
e132
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m135
0
infinite
0
--
IFN-alpha:receptor
--
e133
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m136
0
infinite
0
--
IFN-alpha:receptor:STAT1
--
e134
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m137
0
infinite
0
--
IFN-beta:receptor
--
e135
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m138
0
infinite
0
--
IFN-beta:receptor:STAT1
--
e136
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m139
0
infinite
0
--
IGF:IGFR-1
--
e137
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m140
0
infinite
0
--
IGF-IGFR1:STAT3
--
e138
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m141
0
infinite
0
--
RGS7
--
e139
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m142
0
infinite
0
--
Class A GPCR:Chemokine:Beta-gamma:GDP:alpha G protein
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
GIPC
--
e140
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m143
0
infinite
0
--
RGS19:GIPC
--
e141
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m144
0
infinite
0
--
IGFR1
--
e142
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m145
0
infinite
0
--
IGFR1:RGS19:GIPC
--
e143
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m146
0
infinite
0
--
RGS19:GIPC:TrkA
--
e145
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m148
0
infinite
0
--
GRK2
--
e146
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m149
0
infinite
0
--
GRK5
--
e147
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m150
0
infinite
0
--
--
e148
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m151
0
infinite
0
--
--
e149
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m152
0
infinite
0
--
Class A GPCR:Chemokine:Beta-gamma:GTP:alpha G protein
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
--
e150
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m153
0
infinite
0
--
--
e151
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m154
0
infinite
0
--
--
e152
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m155
0
infinite
0
--
--
e153
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m156
0
infinite
0
--
--
e154
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m157
0
infinite
0
--
--
e155
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m158
0
infinite
0
--
--
e156
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m159
0
infinite
0
--
--
e157
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m160
0
infinite
0
--
--
e158
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m161
0
infinite
0
--
--
e159
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m162
0
infinite
0
--
Chemokine:Class A GPCR:Beta-gamma G protein
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
--
e160
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m163
0
infinite
0
--
GRK6
--
e161
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m164
0
infinite
0
--
IFN
--
e162
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m165
0
infinite
0
--
Synucleins
--
e164
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m167
0
infinite
0
--
Synucleins{p}
--
e165
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m168
0
infinite
0
--
Phosducin
--
e166
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m169
0
infinite
0
--
Phosducin{p}
--
e167
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m170
0
infinite
0
--
csml-variable:Double
m171
0
infinite
0
--
GRK:PI3K
--
e169
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m172
0
infinite
0
--
GTP:alpha G protein
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
GAP
--
e170
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m173
0
infinite
0
--
GRK:GAP
--
e171
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m174
0
infinite
0
--
Galphaq
--
e172
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m176
0
infinite
0
--
Galphaq:GRK
--
e173
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m177
0
infinite
0
--
Beta Gamma G protein:GRK
--
e174
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m178
0
infinite
0
--
GRK:ERK
--
e175
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m180
0
infinite
0
--
GRK:AKT
--
e176
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m182
0
infinite
0
--
GRK2:G beta Gamma
--
e177
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m183
0
infinite
0
--
GRK3
--
e178
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m184
0
infinite
0
--
GRK3:Beta Gamma G protein
--
e179
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m186
0
infinite
0
--
Chemokine:Class A GPCR{p}:Beta-gamma G protein
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
Galphaq:GRK3
--
e180
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m187
0
infinite
0
--
Galphaq:GRK2
--
e181
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m188
0
infinite
0
--
p105
--
e182
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m189
0
infinite
0
--
GRK5:p105
--
e183
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m190
0
infinite
0
--
GRK5:p105{p}
--
e184
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m191
0
infinite
0
--
SRC
--
e185
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m192
0
infinite
0
--
RAF-1
--
e186
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m193
0
infinite
0
--
Beta arrestin2:RAF-1:SRC
--
e187
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m194
0
infinite
0
--
Ligand:CXCR4
--
e188
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m195
0
infinite
0
--
ERK{active}
--
e189
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m196
10
infinite
0
--
second messenger dependent protein kinase
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
Ligand:PAR-2
--
e190
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m197
0
infinite
0
--
Ligand:Beta 2 adrenergic receptor
--
e191
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m198
0
infinite
0
--
Ligand:Angiotensin II type IA
--
e192
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m199
0
infinite
0
--
beta-arrestin:ERK
--
e193
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m200
0
infinite
0
--
csml-variable:Double
m201
10
infinite
0
--
beta arrestin:ERK{p}
--
e195
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m202
0
infinite
0
--
beta-arrestin
--
e196
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m203
10
infinite
0
TRANSPATH | MO000017072 |
--
csml-variable:Double
m204
10
infinite
0
--
CSF-1
--
e198
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m205
0
infinite
0
--
CSF-1{active}
--
e199
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m206
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
beta-arrestin1
--
e20
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m20
10
infinite
0
InterPro | IPR000698 |
TRANSPATH | MO000017073 |
--
JNK3:beta arrestin2
--
e200
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m207
0
infinite
0
--
ASK1
--
e201
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m208
0
infinite
0
--
JNK3:beta arrestin 2: ASK1
--
e202
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m209
0
infinite
0
--
beta-arrestin:NF-kappaB
--
e203
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m210
0
infinite
0
--
IKappaB-alpha
--
e204
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m211
0
infinite
0
--
beta arrestin1:IKappaB-alpha
--
e205
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m212
0
infinite
0
--
beta arrestin2:IkkapB-alpha
--
e206
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m213
0
infinite
0
--
NF-kappaB{active}
--
e207
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m214
10
infinite
0
TRANSPATH | MO000000058 |
--
csml-variable:Double
m215
0
infinite
0
--
NF-KappaB{active}:DNA
--
e209
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m216
0
infinite
0
--
beta-arrestin2
--
e21
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m21
10
infinite
0
InterPro | IPR000698 |
TRANSPATH | MO000017074 |
--
TRAF6
--
e210
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m218
0
infinite
0
--
TRAF6{ub}
--
e211
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m220
0
infinite
0
--
TRAF6{ub} oligomer
--
e212
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m221
0
infinite
0
--
csml-variable:Double
m222
10
infinite
0
--
IKK{active}
--
e214
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m223
0
infinite
0
--
IKK
--
e215
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m224
0
infinite
0
--
LPS:TLR4
--
e216
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m225
0
infinite
0
--
IL-1:IL-1R
--
e217
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m226
0
infinite
0
--
beta arrestin1:TRAF6
--
e218
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m227
0
infinite
0
--
beta arrestin2:TRAF6
--
e219
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m228
0
infinite
0
--
Class B GPCR: Chemokine
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
Class B GPCR:Chemokine:Beta-gamma:GDP:alpha G protein
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
Class B GPCR:Chemokine:Beta-gamma:GTP:alpha G protein
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
Chemokine:Class B GPCR:Beta-gamma G protein
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
Chemokine:Class B GPCR{p}:Beta-gamma G protein
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
Chemokine: Calss A GPCR{p}:Beta-gamma G protein:Beta arrestin2
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
Chemokine: Calss B GPCR{p}:Beta-gamma G protein:Beta arrestin1
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Chemokine: Calss B GPCR{p}:Beta-gamma G protein:Beta arrestin2
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
Chemokine: Calss A GPCR{p}:Beta-gamma G protein:Beta arrestin1
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
Chemokine:Class A GPCR{p}:Beta-gamma G protein
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
Chemokine: Calss B GPCR{p}:Beta-gamma G protein:Beta arrestin2
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
Chemokine: Calss B GPCR{p}:Beta-gamma G protein:Beta arrestin1
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
C5a:C5aR
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
CD88
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
C5a:CD88
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
Superoxide anion
--
e38
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
PGE2
--
e39
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IL-1
--
e40
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m40
0
infinite
0
--
TNF
--
e41
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m41
0
infinite
0
--
FPR1
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
N-formylated methionine
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
FPR1: N-formylated methionine
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m44
0
infinite
0
--
fMLP
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
FPR1: fMLP
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
FPRL1:fMLP
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
endogenous ligand
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m48
0
infinite
0
--
FPRL2: endogenous ligand
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
Beta Gamma Grotein
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Chemokine
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
Nonformylated bacterial protein
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
FPR1: Nonformylated bacterial protein
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
FPRL1: Nonformylated bacterial protein
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m65
0
infinite
0
--
annexin 1
--
e66
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
FPR1:aneexin1
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
FPLR1:annexin 1
--
e68
cso30:c:Complex
cso30:i:CC_NuclearEnvelopeLumen
--
--
csml-variable:Double
m68
0
infinite
0
--
Serum amyloid A
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
Serum amyloid A: FPR1
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
Serum amyloid A: FPRL1
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
amyloid beta peptide
--
e72
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
amyloid beta peptide: FPR1
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
amyloid beta peptide: FPRL1
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
NO
--
e75
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
PARs
--
e78
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
PARs{active}
--
e79
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
IL-1alpha
--
e80
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m80
0
infinite
0
--
PAR2 receptor activating peptides
--
e81
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m81
0
infinite
0
--
IL-8
--
e82
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m82
0
infinite
0
--
NK-1R
--
e83
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
SP
--
e84
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
NK-1R:SP
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
ROS
--
e86
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m86
0
infinite
0
--
PGD2
--
e87
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m87
0
infinite
0
--
SP
--
e88
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m88
0
infinite
0
--
ET-1:receptor
--
e89
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m89
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
cox-2
--
e90
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
GM-CSF
--
e91
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m92
0
infinite
0
--
ET-1:ETAR
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m93
0
infinite
0
--
ET-2:receptor
--
e93
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m94
0
infinite
0
--
MMp2
--
e94
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m95
0
infinite
0
--
MMp9
--
e95
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m96
0
infinite
0
--
superoxide
--
e96
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m97
0
infinite
0
--
02-
--
e97
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m98
0
infinite
0
--
PAF:PAFR
--
e98
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m99
0
infinite
0
--
LTB4:LTB4R1
--
e99
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m100
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m5*m11*0.1
nodelay
--
0
PMID: 17456803 In the absence of agonist, the Beta{gamma}-subunit associates with the GDP-bound {alpha}-subunit.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m22*m6*0.1
nodelay
--
0
PMID: 17456803 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c277 : 1
stoichiometry:c278 : 1
stoichiometry:c279 : 1
m111*m109*0.1
nodelay
--
0
PMID: 17456803,12829604 In humans, EMR2 and CD97 were identified as receptors for cell surface chondroitin sulfate , suggesting that the ligand for EMR1 may be a proteoglycan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c280 : 1
stoichiometry:c281 : 1
stoichiometry:c282 : 1
m110*m114*0.1
nodelay
--
0
PMID: 17456803,12829604 In humans, EMR2 and CD97 were identified as receptors for cell surface chondroitin sulfate , suggesting that the ligand for EMR1 may be a proteoglycan.
p102
p102
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c283 : 1
stoichiometry:c285 : 1
stoichiometry:c286 : 1
stoichiometry:c284 : 1
m40*m155666*0.1
nodelay
--
0
PMID: 17456803,3095921 Jakway and DeFranco first showed that pretreatment of the macrophage cell line P388D1 with PTx reduced the production of IL-1 in response to LPS.
p103
p103
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c287 : 1
stoichiometry:c288 : 1
stoichiometry:c289 : 1
m155666*m117*0.1
nodelay
--
0
PMID: 17456803,2511200 Further, LPS stimulation caused G{alpha}i2 phosphorylation in these cells, implicating this G-protein as a player in LPS signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c290 : 1
stoichiometry:c292 : 1
stoichiometry:c291 : 1
m155666*0.1
nodelay
--
0
PMID: 17456803,8423328,2844658 In mouse peritoneal macrophages, PTx inhibited LPS-dependent NO production but amplified TNF protein production, although others reported no effect of this inhibitor on TNF secretion
p105
p105
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c293 : 1
stoichiometry:c295 : 1
stoichiometry:c296 : 1
stoichiometry:c294 : 1
m41*m155666*m116*0.1
nodelay
--
0
p106
p106
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c297 : 1
stoichiometry:c299 : 1
stoichiometry:c300 : 1
stoichiometry:c298 : 1
m121*m155666*0.1
nodelay
--
0
PMID: 17456803,15201703,12701623,11303728 At the level of signaling, PTx reduced LPS-mediated activation of p38, ERK1/2 and AP-1, without affecting NF-{kappa}B activation
p106
p107
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c301 : 1
stoichiometry:c304 : 1
stoichiometry:c308 : 1
stoichiometry:c441 : 1
stoichiometry:c305 : 1
m155666*m549*0.1
nodelay
--
0
PMID: 17456803,15201703,12701623,11303728 At the level of signaling, PTx reduced LPS-mediated activation of p38, ERK1/2 and AP-1, without affecting NF-{kappa}B activation
p106
p108
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c302 : 1
stoichiometry:c306 : 1
stoichiometry:c309 : 1
stoichiometry:c442 : 1
stoichiometry:c307 : 1
m155666*m554*0.1
nodelay
--
0
PMID: 17456803,15201703,12701623,11303728 At the level of signaling, PTx reduced LPS-mediated activation of p38, ERK1/2 and AP-1, without affecting NF-{kappa}B activation
p106
p109
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c303 : 1
stoichiometry:c310 : 1
stoichiometry:c311 : 1
stoichiometry:c312 : 1
m155666*m219*0.1
nodelay
--
0
PMID: 17456803,15201703,12701623,11303728 At the level of signaling, PTx reduced LPS-mediated activation of p38, ERK1/2 and AP-1, without affecting NF-{kappa}B activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m23*m12*0.1
nodelay
--
0
PMID: 17456803 Agonist occupation of GPCRs stimulates a change in conformation of the receptor, which couples the receptor to the G-protein and promotes the exchange of GDP for GTP on the {alpha}-subunit.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c313 : 1
stoichiometry:c315 : 1
stoichiometry:c314 : 1
m41*m126*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c316 : 1
stoichiometry:c318 : 1
stoichiometry:c317 : 1
m41*m117*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c319 : 1
stoichiometry:c320 : 1
stoichiometry:c321 : 1
m125*m41*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
p110
p113
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c322 : 1
stoichiometry:c323 : 1
stoichiometry:c324 : 1
m104*m125*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
p110
p114
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c325 : 1
stoichiometry:c326 : 1
stoichiometry:c327 : 1
m104*m117*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
p110
p115
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c328 : 1
stoichiometry:c329 : 1
stoichiometry:c330 : 1
m104*m126*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c331 : 1
stoichiometry:c333 : 1
stoichiometry:c332 : 1
m128*m126*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c334 : 1
stoichiometry:c335 : 1
stoichiometry:c336 : 1
m128*m125*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c337 : 1
stoichiometry:c338 : 1
m128*m117*0.1
nodelay
--
0
PMID: 17456803,15788486 For example, LPS-induced TNF, IL-10 and thrombaxane B2 protein production was reduced in peritoneal macrophages derived from mice lacking G{alpha}i2 or G{alpha}i1/3
p119
p119
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c339 : 1
stoichiometry:c340 : 1
stoichiometry:c341 : 1
m35*m129*0.1
nodelay
--
0
PMID: 17456803,10233875,8316840,8486684,11359849 While PTx-sensitive G-proteins can regulate GPCR and TLR signaling in macrophages, PTx-insensitive G-proteins appear to occupy a more conventional signaling role by coupling several chemotactic GPCRs [e.g., CXCR2, C5aR, C3aR, FPR and the IL-8 receptor (IL-8R)] to activation of NF-{kappa}B
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m24*0.1
nodelay
--
0
PMID: 17456803 Agonist occupation of GPCRs stimulates a change in conformation of the receptor, which couples the receptor to the G-protein and promotes the exchange of GDP for GTP on the {alpha}-subunit.
p119
p120
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c342 : 1
stoichiometry:c343 : 1
stoichiometry:c344 : 1
m131*m129*0.1
nodelay
--
0
PMID: 17456803,10233875,8316840,8486684,11359849 While PTx-sensitive G-proteins can regulate GPCR and TLR signaling in macrophages, PTx-insensitive G-proteins appear to occupy a more conventional signaling role by coupling several chemotactic GPCRs [e.g., CXCR2, C5aR, C3aR, FPR and the IL-8 receptor (IL-8R)] to activation of NF-{kappa}B
p119
p121
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c345 : 1
stoichiometry:c346 : 1
stoichiometry:c347 : 1
m132*m129*0.1
nodelay
--
0
PMID: 17456803,10233875,8316840,8486684,11359849 While PTx-sensitive G-proteins can regulate GPCR and TLR signaling in macrophages, PTx-insensitive G-proteins appear to occupy a more conventional signaling role by coupling several chemotactic GPCRs [e.g., CXCR2, C5aR, C3aR, FPR and the IL-8 receptor (IL-8R)] to activation of NF-{kappa}B
p119
p122
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c348 : 1
stoichiometry:c349 : 1
stoichiometry:c350 : 1
m133*m129*0.1
nodelay
--
0
PMID: 17456803,10233875,8316840,8486684,11359849 While PTx-sensitive G-proteins can regulate GPCR and TLR signaling in macrophages, PTx-insensitive G-proteins appear to occupy a more conventional signaling role by coupling several chemotactic GPCRs [e.g., CXCR2, C5aR, C3aR, FPR and the IL-8 receptor (IL-8R)] to activation of NF-{kappa}B
p119
p123
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c351 : 1
stoichiometry:c352 : 1
stoichiometry:c353 : 1
m134*m129*0.1
nodelay
--
0
PMID: 17456803,10233875,8316840,8486684,11359849 While PTx-sensitive G-proteins can regulate GPCR and TLR signaling in macrophages, PTx-insensitive G-proteins appear to occupy a more conventional signaling role by coupling several chemotactic GPCRs [e.g., CXCR2, C5aR, C3aR, FPR and the IL-8 receptor (IL-8R)] to activation of NF-{kappa}B
p124
p124
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c354 : 1
stoichiometry:c355 : 1
stoichiometry:c359 : 1
stoichiometry:c356 : 1
m135*m136*m1357*0.1
nodelay
--
0
PMID: 17456803,11046044,11301323,16382134 Gbeta2L1 also has roles beyond regulation of GPCR signaling; it mediated the recruitment of STAT1 and STAT3 to the IFN-{alpha}/beta and the tyrosine kinase insulin-like growth factor receptor 1 (IGFR-1) receptors, respectively
p124
p125
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c357 : 1
stoichiometry:c358 : 1
stoichiometry:c360 : 1
stoichiometry:c361 : 1
m138*m135*m1357*0.1
nodelay
--
0
PMID: 17456803,11046044,11301323,16382134 Gbeta2L1 also has roles beyond regulation of GPCR signaling; it mediated the recruitment of STAT1 and STAT3 to the IFN-{alpha}/beta and the tyrosine kinase insulin-like growth factor receptor 1 (IGFR-1) receptors, respectively
p124
p126
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c362 : 1
stoichiometry:c363 : 1
stoichiometry:c365 : 1
stoichiometry:c364 : 1
m140*m135*m1360*0.1
nodelay
--
0
PMID: 17456803,11046044,11301323,16382134 Gbeta2L1 also has roles beyond regulation of GPCR signaling; it mediated the recruitment of STAT1 and STAT3 to the IFN-{alpha}/beta and the tyrosine kinase insulin-like growth factor receptor 1 (IGFR-1) receptors, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c366 : 1
stoichiometry:c367 : 1
m155666*0.1
nodelay
--
0
PMID: 17456803,11886441 In addition, Hausmann et al. showed that LPS and TNF increased RGS7 mRNA levels markedly in the macrophage-like cell line RAW264.7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c368 : 1
stoichiometry:c369 : 1
m175*0.1
nodelay
--
0
PMID: 17456803,11886441 In addition, Hausmann et al. showed that LPS and TNF increased RGS7 mRNA levels markedly in the macrophage-like cell line RAW264.7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c370 : 1
stoichiometry:c371 : 1
stoichiometry:c372 : 1
m44517*m143*0.1
nodelay
--
0
PMID: 17456803, 9770488 RGS19 [also known as Galpha-interacting protein (GAIP) interacts specifically with the PDZ-containing protein, GAIP-interacting protein, C-terminus (GIPC)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m25*0.1
nodelay
--
0
PMID: 17456803 The GTP-bound {alpha}-subunit dissociates from the beta{gamma}-subunit; the free subunits then regulate effector enzymes positively or negatively, ultimately leading to a biological response.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c373 : 1
stoichiometry:c374 : 1
stoichiometry:c375 : 1
m144*m145*0.1
nodelay
--
0
PMID: 17456803, 11751850 Interaction of the RGS19/GIPC heterodimer with the IGFR-1 consolidates IGF-1 signaling to MAPK activation
p131
p131
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c376 : 1
stoichiometry:c377 : 1
stoichiometry:c378 : 1
m146*m1812*0.1
nodelay
--
0
PMID: 17456803, 11751850 Interaction of the RGS19/GIPC heterodimer with the IGFR-1 consolidates IGF-1 signaling to MAPK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c379 : 1
stoichiometry:c380 : 1
stoichiometry:c381 : 1
m144*m1922*0.1
nodelay
--
0
PMID: 17456803, 11251075 RGS19 and GAIC can also form a complex with the nerve growth factor receptor, TrkA, , although it remains unclear how this complex affects signaling through these receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c382 : 1
stoichiometry:c383 : 1
1.0*0.1
nodelay
--
0
PMID: 17456803 Array data suggest that GRK2 and -6 mRNA expression is down-regulated by LPS in bone marrow-derived macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c385 : 1
stoichiometry:c384 : 1
1.0*0.1
nodelay
--
0
PMID: 17456803 Array data suggest that GRK2 and -6 mRNA expression is down-regulated by LPS in bone marrow-derived macrophages
p135
p135
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c386 : 1
stoichiometry:c391 : 1
stoichiometry:c396 : 1
stoichiometry:c387 : 1
m150*m1591*0.1
nodelay
--
0
PMID: 17456803, 11861327, 12130691, 10094932 Protein expression of GRK2 and -5 was elevated in the lungs of IL-1beta-treated rats while oxygen radicals and the inflammatory cytokines, IL-6 and IFN, reduced GRK2 protein in human T lymphocytes and human PBMC, respectively PMID: 17456803, 12592402 Furthermore, GRK2 and -5 protein expression was down-regulated by LPS in polymorphonuclear neutrophils, thereby augmenting chemokine responsiveness
p135
p136
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c389 : 1
stoichiometry:c392 : 1
stoichiometry:c393 : 1
stoichiometry:c388 : 1
stoichiometry:c394 : 1
stoichiometry:c395 : 1
stoichiometry:c390 : 1
m149*m1591*0.1
nodelay
--
0
PMID: 17456803, 11861327, 12130691, 10094932 Protein expression of GRK2 and -5 was elevated in the lungs of IL-1beta-treated rats while oxygen radicals and the inflammatory cytokines, IL-6 and IFN, reduced GRK2 protein in human T lymphocytes and human PBMC, respectively PMID: 17456803, 11861327, 12130691, 10094932 Protein expression of GRK2 and -5 was elevated in the lungs of IL-1beta-treated rats while oxygen radicals and the inflammatory cytokines, IL-6 and IFN, reduced GRK2 protein in human T lymphocytes and human PBMC, respectively PMID: 17456803, 12592402 Furthermore, GRK2 and -5 protein expression was down-regulated by LPS in polymorphonuclear neutrophils, thereby augmenting chemokine responsiveness
p137
p137
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c397 : 1
stoichiometry:c398 : 1
stoichiometry:c399 : 1
m1961*m1967*0.1
nodelay
--
0
PMID: 17456803, 9575184, 10852916, 10884381 First, GRKs are able to phosphorylate nonreceptor substrates such as tubulin, synucleins and phosducin
p137
p138
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c400 : 1
stoichiometry:c401 : 1
stoichiometry:c402 : 1
m1961*m167*0.1
nodelay
--
0
PMID: 17456803, 9575184, 10852916, 10884381 First, GRKs are able to phosphorylate nonreceptor substrates such as tubulin, synucleins and phosducin
p137
p139
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c403 : 1
stoichiometry:c404 : 1
stoichiometry:c405 : 1
m1961*m169*0.1
nodelay
--
0
PMID: 17456803, 9575184, 10852916, 10884381 First, GRKs are able to phosphorylate nonreceptor substrates such as tubulin, synucleins and phosducin
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m1961*m26*0.1
nodelay
--
0
PMID: 17456803,2836733,7876239,10090766 Desensitization is initiated by phosphorylation of activated GPCRs within the third intracellular loop or the carboxyl-terminal tail by GRKs and/or second messenger-dependent protein kinases
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c406 : 1
stoichiometry:c407 : 1
stoichiometry:c408 : 1
m1961*m171*0.1
nodelay
--
0
PMID: 17456803, 12163475, 12885252, 9826657, 10727532, 16221891, 16142243 In addition, GRKs modulate signaling in a phosphorylation-independent manner by interacting with proteins involved in signaling and trafficking, including PI-3Ks, guanosinetriphosphatase-activating protein, Galphaq and Gbetagamma, ERK and AKT
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c409 : 1
stoichiometry:c410 : 1
stoichiometry:c411 : 1
m173*m1961*0.1
nodelay
--
0
PMID: 17456803, 12163475, 12885252, 9826657, 10727532, 16221891, 16142243 In addition, GRKs modulate signaling in a phosphorylation-independent manner by interacting with proteins involved in signaling and trafficking, including PI-3Ks, guanosinetriphosphatase-activating protein, Galphaq and Gbetagamma, ERK and AKT
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c412 : 1
stoichiometry:c413 : 1
stoichiometry:c414 : 1
m1961*m176*0.1
nodelay
--
0
PMID: 17456803, 12163475, 12885252, 9826657, 10727532, 16221891, 16142243 In addition, GRKs modulate signaling in a phosphorylation-independent manner by interacting with proteins involved in signaling and trafficking, including PI-3Ks, guanosinetriphosphatase-activating protein, Galphaq and Gbetagamma, ERK and AKT
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c415 : 1
stoichiometry:c416 : 1
stoichiometry:c417 : 1
m5*m1961*0.1
nodelay
--
0
PMID: 17456803, 12163475, 12885252, 9826657, 10727532, 16221891, 16142243 In addition, GRKs modulate signaling in a phosphorylation-independent manner by interacting with proteins involved in signaling and trafficking, including PI-3Ks, guanosinetriphosphatase-activating protein, Galphaq and Gbetagamma, ERK and AKT
p140
p144
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c418 : 1
stoichiometry:c419 : 1
stoichiometry:c420 : 1
m179*m1961*0.1
nodelay
--
0
PMID: 17456803, 12163475, 12885252, 9826657, 10727532, 16221891, 16142243 In addition, GRKs modulate signaling in a phosphorylation-independent manner by interacting with proteins involved in signaling and trafficking, including PI-3Ks, guanosinetriphosphatase-activating protein, Galphaq and Gbetagamma, ERK and AKT
p140
p145
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c421 : 1
stoichiometry:c422 : 1
stoichiometry:c423 : 1
m181*m1961*0.1
nodelay
--
0
PMID: 17456803, 12163475, 12885252, 9826657, 10727532, 16221891, 16142243 In addition, GRKs modulate signaling in a phosphorylation-independent manner by interacting with proteins involved in signaling and trafficking, including PI-3Ks, guanosinetriphosphatase-activating protein, Galphaq and Gbetagamma, ERK and AKT
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c424 : 1
stoichiometry:c425 : 1
stoichiometry:c426 : 1
m1984*m5*0.1
nodelay
--
0
PMID: 17456803, 10727532, 10567430, 16339447, 10719047 Binding of GRK2 or -3 to the Gbetagamma complex induces activation of these GRKs while selective binding of GRK2 and -3 to activated Galphaq selectively inhibits Galphaq signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c427 : 1
stoichiometry:c428 : 1
stoichiometry:c429 : 1
m5*m184*0.1
nodelay
--
0
PMID: 17456803, 10727532, 10567430, 16339447, 10719047 Binding of GRK2 or -3 to the Gbetagamma complex induces activation of these GRKs while selective binding of GRK2 and -3 to activated Galphaq selectively inhibits Galphaq signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c430 : 1
stoichiometry:c431 : 1
stoichiometry:c432 : 1
m184*m176*0.1
nodelay
--
0
PMID: 17456803, 10727532, 10567430, 16339447, 10719047 Binding of GRK2 or -3 to the Gbetagamma complex induces activation of these GRKs while selective binding of GRK2 and -3 to activated Galphaq selectively inhibits Galphaq signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c433 : 1
stoichiometry:c434 : 1
stoichiometry:c435 : 1
m176*m1984*0.1
nodelay
--
0
PMID: 17456803, 10727532, 10567430, 16339447, 10719047 Binding of GRK2 or -3 to the Gbetagamma complex induces activation of these GRKs while selective binding of GRK2 and -3 to activated Galphaq selectively inhibits Galphaq signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m19*m26*0.1
nodelay
--
0
PMID: 17456803,2836733,7876239,10090766 Desensitization is initiated by phosphorylation of activated GPCRs within the third intracellular loop or the carboxyl-terminal tail by GRKs and/or second messenger-dependent protein kinases
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c436 : 1
stoichiometry:c437 : 1
stoichiometry:c438 : 1
m1999*m189*0.1
nodelay
--
0
PMID: 17456803, 16980301 GRK5 also bound to and phosphorylated p105, implying that p105 phosphorylation by GRK5 negatively regulates LPS-stimulated ERK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c439 : 1
stoichiometry:c440 : 1
m190*0.1
nodelay
--
0
p152
p152
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c443 : 1
stoichiometry:c444 : 1
stoichiometry:c445 : 1
stoichiometry:c446 : 1
m193*m192*m1966*0.1
nodelay
--
0
PMID: 17456803, 12370187, 12821670, 13679574, 11226259, 10725339, 14711824, 9924018 For example, ARRB2 was required for CXCR4, PAR-2, Beta2-adrenergic receptor, and angiotensin II Type 1A-mediated ERK activation via direct binding to components of the ERK pathway such as SRC and RAF-1
p153
p153
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c447 : 1
stoichiometry:c448 : 1
stoichiometry:c449 : 1
stoichiometry:c450 : 1
m195*m194*m179*0.1
nodelay
--
0
PMID: 17456803, 12370187, 12821670, 13679574, 11226259, 10725339, 14711824, 9924018 For example, ARRB2 was required for CXCR4, PAR-2, Beta2-adrenergic receptor, and angiotensin II Type 1A-mediated ERK activation via direct binding to components of the ERK pathway such as SRC and RAF-1
p153
p154
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c451 : 1
stoichiometry:c452 : 1
stoichiometry:c453 : 1
stoichiometry:c454 : 1
m197*m194*m179*0.1
nodelay
--
0
PMID: 17456803, 12370187, 12821670, 13679574, 11226259, 10725339, 14711824, 9924018 For example, ARRB2 was required for CXCR4, PAR-2, Beta2-adrenergic receptor, and angiotensin II Type 1A-mediated ERK activation via direct binding to components of the ERK pathway such as SRC and RAF-1
p153
p155
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c455 : 1
stoichiometry:c456 : 1
stoichiometry:c457 : 1
stoichiometry:c458 : 1
m198*m194*m179*0.1
nodelay
--
0
PMID: 17456803, 12370187, 12821670, 13679574, 11226259, 10725339, 14711824, 9924018 For example, ARRB2 was required for CXCR4, PAR-2, Beta2-adrenergic receptor, and angiotensin II Type 1A-mediated ERK activation via direct binding to components of the ERK pathway such as SRC and RAF-1
p153
p156
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c459 : 1
stoichiometry:c460 : 1
stoichiometry:c461 : 1
stoichiometry:c462 : 1
m199*m194*m179*0.1
nodelay
--
0
PMID: 17456803, 12370187, 12821670, 13679574, 11226259, 10725339, 14711824, 9924018 For example, ARRB2 was required for CXCR4, PAR-2, Beta2-adrenergic receptor, and angiotensin II Type 1A-mediated ERK activation via direct binding to components of the ERK pathway such as SRC and RAF-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c464 : 1
stoichiometry:c463 : 1
stoichiometry:c465 : 1
m1964*m201*0.1
nodelay
--
0
PMID: 17456803, 12821670, 10725339 Further, direct binding of ARRB to ERK enhanced ERK phosphorylation and targeted it to the cytosol
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c466 : 1
stoichiometry:c467 : 1
m200*0.1
nodelay
--
0
PMID: 17456803, 12821670, 10725339 Further, direct binding of ARRB to ERK enhanced ERK phosphorylation and targeted it to the cytosol
p159
p159
cso30:i:ME_Translocation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c468 : 1
stoichiometry:c469 : 1
stoichiometry:c470 : 1
m202*0.1
nodelay
--
0
PMID: 17456803, 12821670, 10725339 Further, direct binding of ARRB to ERK enhanced ERK phosphorylation and targeted it to the cytosol
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m18*m21*0.1
nodelay
--
0
PMID: 17456803 Class A receptors bind ARRB2 with much higher affinity than ARRB1, and Class B receptors bind both ARRBs with equal affinities.
p160
p160
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c471 : 1
stoichiometry:c473 : 1
stoichiometry:c472 : 1
m2570*m1966*0.1
nodelay
--
0
PMID: 17456803, 11356842 ARRB2, but not ARRB1, activated JNK3 signaling through its ability to act as a scaffold
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c474 : 1
stoichiometry:c475 : 1
m205*0.1
nodelay
--
0
PMID: 17456803, 11756160, 9710599 Activation of a number of receptor tyrosine kinases, including the CSF-1 receptor, which is required for macrophage survival and proliferation , leads to activation of ERK1/2.
p161
p162
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c476 : 1
stoichiometry:c477 : 1
stoichiometry:c478 : 1
m206*m549*0.1
nodelay
--
0
PMID: 17456803, 11756160, 9710599 Activation of a number of receptor tyrosine kinases, including the CSF-1 receptor, which is required for macrophage survival and proliferation , leads to activation of ERK1/2.
p161
p163
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c479 : 1
stoichiometry:c481 : 1
stoichiometry:c480 : 1
m206*m554*0.1
nodelay
--
0
PMID: 17456803, 11756160, 9710599 Activation of a number of receptor tyrosine kinases, including the CSF-1 receptor, which is required for macrophage survival and proliferation , leads to activation of ERK1/2.
p164
p164
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c482 : 1
stoichiometry:c483 : 1
stoichiometry:c484 : 1
m2570*m1966*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c485 : 1
stoichiometry:c486 : 1
stoichiometry:c487 : 1
m208*m207*0.1
nodelay
--
0
PMID: 17456803 The interaction among JNK3, ARRB2 and ASK1 resulted in the assembly of signaling complexes and enhanced phosphorylation of JNK3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c488 : 1
stoichiometry:c489 : 1
stoichiometry:c490 : 1
m203*m129*0.1
nodelay
--
0
PMID: 17456803 ARRBs also regulate macrophage signaling through interaction with NF-{kappa}B, a family of proinflammatory transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c491 : 1
stoichiometry:c492 : 1
stoichiometry:c493 : 1
m211*m1965*0.1
nodelay
--
0
PMID: 17456803,15125834,15173580 ARRB1 and -2 interacted with the I{kappa}B{alpha} component of the NF-{kappa}B signaling complex in a range of cell types including HEK293, HeLa, Jurkat, COS-7 and THP-1 cells
p168
p168
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c498 : 1
stoichiometry:c497 : 1
stoichiometry:c500 : 1
stoichiometry:c499 : 1
m129*m175*0.1
nodelay
--
0
PMID: 17456803, 15173580 Overexpression of ARRB1 or -2 in HeLa cells inhibited TNF-induced NF-{kappa}B activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c494 : 1
stoichiometry:c495 : 1
stoichiometry:c496 : 1
m1966*m211*0.1
nodelay
--
0
PMID: 17456803,15125834,15173580 ARRB1 and -2 interacted with the I{kappa}B{alpha} component of the NF-{kappa}B signaling complex in a range of cell types including HEK293, HeLa, Jurkat, COS-7 and THP-1 cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m27*m20*0.1
nodelay
--
0
PMID: 17456803 Class A receptors bind ARRB2 with much higher affinity than ARRB1, and Class B receptors bind both ARRBs with equal affinities.
p168
p170
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c501 : 1
stoichiometry:c502 : 1
stoichiometry:c504 : 1
stoichiometry:c503 : 1
m175*m129*0.1
nodelay
--
0
PMID: 17456803, 15173580 Overexpression of ARRB1 or -2 in HeLa cells inhibited TNF-induced NF-{kappa}B activation
p171
p171
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c505 : 1
stoichiometry:c506 : 1
stoichiometry:c508 : 1
stoichiometry:c507 : 1
m214*m215*0.1
nodelay
--
0
PMID: 17456803,15125834 Similarly, overexpression of ARRB2 in HEK293 cells inhibited TNF-induced NF-{kappa}B DNA binding, while RNA interference-mediated knockdown of ARRB2 had an opposing effect
p172
p172
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c509 : 1
stoichiometry:c511 : 1
stoichiometry:c527 : 1
stoichiometry:c536 : 1
stoichiometry:c510 : 1
m218*m225*0.1
nodelay
--
0
PMID: 17456803,11057907,10215628 In response to TLR or IL-1 family ligands, TNF receptor-associated factor (TRAF)6 is auto-ubiquitinated, oligomerizes and subsequently initiates downstream signaling events, including activation of IKK and JNK PMID: 17456803,16378096 ARRB1 and -2 interacted with TRAF6 upon TLR4 or IL-1R activation and prevented TRAF6 auto-ubiquitination, oligomerization and IKK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c512 : 1
stoichiometry:c513 : 1
m220*0.1
nodelay
--
0
PMID: 17456803,11057907,10215628 In response to TLR or IL-1 family ligands, TNF receptor-associated factor (TRAF)6 is auto-ubiquitinated, oligomerizes and subsequently initiates downstream signaling events, including activation of IKK and JNK
p174
p174
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c514 : 1
stoichiometry:c515 : 1
stoichiometry:c516 : 1
m221*m217*0.1
nodelay
--
0
PMID: 17456803,11057907,10215628 In response to TLR or IL-1 family ligands, TNF receptor-associated factor (TRAF)6 is auto-ubiquitinated, oligomerizes and subsequently initiates downstream signaling events, including activation of IKK and JNK
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c517 : 1
stoichiometry:c519 : 1
stoichiometry:c518 : 1
m218*m226*0.1
nodelay
--
0
PMID: 17456803,11057907,10215628 In response to TLR or IL-1 family ligands, TNF receptor-associated factor (TRAF)6 is auto-ubiquitinated, oligomerizes and subsequently initiates downstream signaling events, including activation of IKK and JNK
p174
p176
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c520 : 1
stoichiometry:c521 : 1
stoichiometry:c522 : 1
m221*m224*0.1
nodelay
--
0
PMID: 17456803,11057907,10215628 In response to TLR or IL-1 family ligands, TNF receptor-associated factor (TRAF)6 is auto-ubiquitinated, oligomerizes and subsequently initiates downstream signaling events, including activation of IKK and JNK
p177
p177
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c523 : 1
stoichiometry:c524 : 1
stoichiometry:c525 : 1
stoichiometry:c526 : 1
m218*m226*m1965*0.1
nodelay
--
0
PMID: 17456803,16378096 ARRB1 and -2 interacted with TRAF6 upon TLR4 or IL-1R activation and prevented TRAF6 auto-ubiquitination, oligomerization and IKK activation
p177
p178
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c528 : 1
stoichiometry:c529 : 1
stoichiometry:c530 : 1
stoichiometry:c531 : 1
m225*m1965*m218*0.1
nodelay
--
0
PMID: 17456803,16378096 ARRB1 and -2 interacted with TRAF6 upon TLR4 or IL-1R activation and prevented TRAF6 auto-ubiquitination, oligomerization and IKK activation
p177
p179
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c532 : 1
stoichiometry:c533 : 1
stoichiometry:c534 : 1
stoichiometry:c535 : 1
m218*m226*m1966*0.1
nodelay
--
0
PMID: 17456803,16378096 ARRB1 and -2 interacted with TRAF6 upon TLR4 or IL-1R activation and prevented TRAF6 auto-ubiquitination, oligomerization and IKK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m27*m21*0.1
nodelay
--
0
PMID: 17456803 Class A receptors bind ARRB2 with much higher affinity than ARRB1, and Class B receptors bind both ARRBs with equal affinities.
p177
p180
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c537 : 1
stoichiometry:c538 : 1
stoichiometry:c539 : 1
stoichiometry:c540 : 1
m218*m225*m1966*0.1
nodelay
--
0
PMID: 17456803,16378096 ARRB1 and -2 interacted with TRAF6 upon TLR4 or IL-1R activation and prevented TRAF6 auto-ubiquitination, oligomerization and IKK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m18*m20*0.1
nodelay
--
0
PMID: 17456803 Class A receptors bind ARRB2 with much higher affinity than ARRB1, and Class B receptors bind both ARRBs with equal affinities.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m249*m6*0.1
nodelay
--
0
PMID: 17456803 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m28*0.1
nodelay
--
0
PMID: 17456803 The classes are distinguished further on the basis of their association with ARRB during receptor internalization; ARRBs dissociate from Class A receptors prior to internalization, and ARRBs remain associated with Class B receptors throughout receptor internalization
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m31*0.1
nodelay
--
0
PMID: 17456803 The classes are distinguished further on the basis of their association with ARRB during receptor internalization; ARRBs dissociate from Class A receptors prior to internalization, and ARRBs remain associated with Class B receptors throughout receptor internalization
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m18*0.1
nodelay
--
0
PMID: 17456803 The classes are distinguished further on the basis of their association with ARRB during receptor internalization; ARRBs dissociate from Class A receptors prior to internalization, and ARRBs remain associated with Class B receptors throughout receptor internalization PMID: 17456803 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m30*0.1
nodelay
--
0
PMID: 17456803 The classes are distinguished further on the basis of their association with ARRB during receptor internalization; ARRBs dissociate from Class A receptors prior to internalization, and ARRBs remain associated with Class B receptors throughout receptor internalization PMID: 17456803 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m29*0.1
nodelay
--
0
PMID: 17456803 The classes are distinguished further on the basis of their association with ARRB during receptor internalization; ARRBs dissociate from Class A receptors prior to internalization, and ARRBs remain associated with Class B receptors throughout receptor internalization PMID: 17456803 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m12280*m6571*0.1
nodelay
--
0
PMID: 17456803,8011297 The complement component C5a acts as a potent neutrophil and monocyte chemoattractant via the GPCR C5aR/CD88
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m12280*m36*0.1
nodelay
--
0
PMID: 17456803,8011297 The complement component C5a acts as a potent neutrophil and monocyte chemoattractant via the GPCR C5aR/CD88
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m35*0.1
nodelay
--
0
PMID: 17456803,12176911 It also up-regulates the expression of other complement receptors such as CR1 and CR3 on leukocytes, thus enhancing phagocytic capacity and the respiratory burst
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m35*0.1
nodelay
--
0
PMID: 17456803,12176911 It also up-regulates the expression of other complement receptors such as CR1 and CR3 on leukocytes, thus enhancing phagocytic capacity and the respiratory burst
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m35*0.1
nodelay
--
0
PMID: 17456803,6300969,1690130,6809882 Further, C5a triggered the production of superoxide anion and PGE2 from resident and elicited mouse peritoneal macrophages, as well as TNF and IL-1 from human and mouse macrophage populations
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m13*m12*0.1
nodelay
--
0
PMID: 17456803 Agonist occupation of GPCRs stimulates a change in conformation of the receptor, which couples the receptor to the G-protein and promotes the exchange of GDP for GTP on the {alpha}-subunit.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m35*0.1
nodelay
--
0
PMID: 17456803,6300969,1690130,6809882 Further, C5a triggered the production of superoxide anion and PGE2 from resident and elicited mouse peritoneal macrophages, as well as TNF and IL-1 from human and mouse macrophage populations
p31
p31
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c82 : 1
stoichiometry:c81 : 1
m35*m40*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m41*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m43*m42*0.1
nodelay
--
0
PMID: 17456803 FPR1 triggers cellular locomotion upon recognition of N-formylated methionine from bacterial proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m45*m42*0.1
nodelay
--
0
PMID: 17456803,16684671,2161213,8198572 The classic FPR1 agonist, fMLP, has a much higher affinity for FPR1 than FPRL1, and ectopic expression studies suggest that FPRL2 does not recognize this ligand
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
m38196*m45*0.1
nodelay
--
0
PMID: 17456803,16684671,2161213,8198572 The classic FPR1 agonist, fMLP, has a much higher affinity for FPR1 than FPRL1, and ectopic expression studies suggest that FPRL2 does not recognize this ligand
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m48*m12225*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m42*m63*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m63*m38196*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m66*m42*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m14*0.1
nodelay
--
0
PMID: 17456803 Agonist occupation of GPCRs stimulates a change in conformation of the receptor, which couples the receptor to the G-protein and promotes the exchange of GDP for GTP on the {alpha}-subunit.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m38196*m66*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m42*m69*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m69*m38196*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m72*m42*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m72*m38196*0.1
nodelay
--
0
PMID: 17456803,15623572,11602630,15187149,9892621,11160457 However, an endogenous peptide ligand for FPRL2 was identified recently , and it is now clear that FPR1 and FPRL1 can also detect nonformylated bacterial proteins , as well as endogenous ligands such as annexin 1 , serum amyloid A , and amyloid beta-peptide of 42 residues
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
m46*0.1
nodelay
--
0
PMID: 17456803,11818447 FPRs also regulate the process of macrophage activation; fMLP induced the expression of inducible NO synthetase (iNOS) and production of NO in mouse peritoneal macrophages and the secretion of IL-1{alpha}, IL-1beta, and IL-6 in human PBMC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m93479*0.1
nodelay
--
0
PMID: 17456803,11818447 FPRs also regulate the process of macrophage activation; fMLP induced the expression of inducible NO synthetase (iNOS) and production of NO in mouse peritoneal macrophages and the secretion of IL-1{alpha}, IL-1beta, and IL-6 in human PBMC
p47
p47
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m47*m2134*0.1
nodelay
--
0
PMID: 17456803,10872839,10611407 Activation of FPR or FPRL1 by fMLP in human monocytes/macrophages rapidly induced serine phosphorylation and heterologous desensitization of CCR5 and CXCR4
p47
p48
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m46*m2134*0.1
nodelay
--
0
PMID: 17456803,10872839,10611407 Activation of FPR or FPRL1 by fMLP in human monocytes/macrophages rapidly induced serine phosphorylation and heterologous desensitization of CCR5 and CXCR4
p47
p49
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m46*m2033*0.1
nodelay
--
0
PMID: 17456803,10872839,10611407 Activation of FPR or FPRL1 by fMLP in human monocytes/macrophages rapidly induced serine phosphorylation and heterologous desensitization of CCR5 and CXCR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m15*0.1
nodelay
--
0
PMID: 17456803 The GTP-bound {alpha}-subunit dissociates from the beta{gamma}-subunit; the free subunits then regulate effector enzymes positively or negatively, ultimately leading to a biological response.
p47
p50
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m47*m2033*0.1
nodelay
--
0
PMID: 17456803,10872839,10611407 Activation of FPR or FPRL1 by fMLP in human monocytes/macrophages rapidly induced serine phosphorylation and heterologous desensitization of CCR5 and CXCR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
m78*0.1
nodelay
--
0
PMID: 17456803 The PARs are a family of GPCRs that are activated upon proteolytic cleavage of their amino terminal exodomain.
p52
p52
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m1909*m1420*0.1
nodelay
--
0
PMID: 17456803,12805069,16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p46
p53
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c144 : 1
stoichiometry:c143 : 1
m93364*m46*0.1
nodelay
--
0
PMID: 17456803,11818447 FPRs also regulate the process of macrophage activation; fMLP induced the expression of inducible NO synthetase (iNOS) and production of NO in mouse peritoneal macrophages and the secretion of IL-1{alpha}, IL-1beta, and IL-6 in human PBMC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c147 : 1
stoichiometry:c146 : 1
m80*m46*0.1
nodelay
--
0
PMID: 17456803,11818447 FPRs also regulate the process of macrophage activation; fMLP induced the expression of inducible NO synthetase (iNOS) and production of NO in mouse peritoneal macrophages and the secretion of IL-1{alpha}, IL-1beta, and IL-6 in human PBMC
p46
p55
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c150 : 1
stoichiometry:c149 : 1
m93248*m46*0.1
nodelay
--
0
PMID: 17456803,11818447 FPRs also regulate the process of macrophage activation; fMLP induced the expression of inducible NO synthetase (iNOS) and production of NO in mouse peritoneal macrophages and the secretion of IL-1{alpha}, IL-1beta, and IL-6 in human PBMC
p52
p56
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c152 : 1
stoichiometry:c153 : 1
m1909*m1920*0.1
nodelay
--
0
PMID: 17456803,12805069,16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p57
p57
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c156 : 1
stoichiometry:c155 : 1
m93248*m3055*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p57
p58
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c159 : 1
stoichiometry:c158 : 1
m2226*m93248*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p59
p59
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c162 : 1
stoichiometry:c161 : 1
m93710*m3055*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c17 : 1
stoichiometry:c16 : 1
m16*m1961*0.1
nodelay
--
0
PMID: 17456803,2836733,7876239,10090766 Desensitization is initiated by phosphorylation of activated GPCRs within the third intracellular loop or the carboxyl-terminal tail by GRKs and/or second messenger-dependent protein kinases
p59
p60
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c165 : 1
stoichiometry:c164 : 1
m2226*m93710*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p61
p61
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c168 : 1
stoichiometry:c167 : 1
m1920*m81*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p59
p62
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m2226*m93364*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p59
p63
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c174 : 1
stoichiometry:c173 : 1
m93248*m2226*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
p59
p64
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c177 : 1
stoichiometry:c176 : 1
m82*m2226*0.1
nodelay
--
0
PMID: 17456803, 12805069, 16000389 Thrombin-induced activation of PAR-1 and -2 in human peripheral monocytes or macrophages induced the release of the proinflammatory mediators MCP-1 (CCL2) and IL-6, while stimulation of PAR-2 by PAR-2 receptor-activating peptides in human peripheral blood monocytes increased the production of IL-1beta, IL-6, and IL-8
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m84*m83*0.1
nodelay
--
0
PMID: 17456803,1380279,9548509 Rodent and human macrophages express the neurokinin-1 receptor (NK-1R or TACR1), which signals in response to neuropeptide substance P (SP)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
stoichiometry:c183 : 1
m85*m41*0.1
nodelay
--
0
PMID: 17456803,8982105,2457950,7573817 SP induced the protein expression of IL-1, TNF, and IL-6 in human blood monocytes and human monocyte-derived macrophages and increased production of reactive oxygen species and PGD2 secretion from guinea pig alveolar macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c185 : 1
stoichiometry:c186 : 1
m40*m85*0.1
nodelay
--
0
PMID: 17456803,8982105,2457950,7573817 SP induced the protein expression of IL-1, TNF, and IL-6 in human blood monocytes and human monocyte-derived macrophages and increased production of reactive oxygen species and PGD2 secretion from guinea pig alveolar macrophages
p66
p68
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m85*m93248*0.1
nodelay
--
0
PMID: 17456803,8982105,2457950,7573817 SP induced the protein expression of IL-1, TNF, and IL-6 in human blood monocytes and human monocyte-derived macrophages and increased production of reactive oxygen species and PGD2 secretion from guinea pig alveolar macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m85*0.1
nodelay
--
0
PMID: 17456803,8982105,2457950,7573817 SP induced the protein expression of IL-1, TNF, and IL-6 in human blood monocytes and human monocyte-derived macrophages and increased production of reactive oxygen species and PGD2 secretion from guinea pig alveolar macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c20 : 1
stoichiometry:c19 : 1
m16*m19*0.1
nodelay
--
0
PMID: 17456803,2836733,7876239,10090766 Desensitization is initiated by phosphorylation of activated GPCRs within the third intracellular loop or the carboxyl-terminal tail by GRKs and/or second messenger-dependent protein kinases
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c193 : 1
m85*0.1
nodelay
--
0
PMID: 17456803,8982105,2457950,7573817 SP induced the protein expression of IL-1, TNF, and IL-6 in human blood monocytes and human monocyte-derived macrophages and increased production of reactive oxygen species and PGD2 secretion from guinea pig alveolar macrophages
p71
p71
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c195 : 1
stoichiometry:c196 : 1
m155666*m93961*0.1
nodelay
--
0
PMID: 17456803,1380279,9548509,10573219 Expression of NK-1R and SP protein was induced in rat and human macrophages in response to LPS , suggesting the existence of an autocrine pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c198 : 1
stoichiometry:c199 : 1
m155666*m88*0.1
nodelay
--
0
PMID: 17456803,1380279,9548509,10573219 Expression of NK-1R and SP protein was induced in rat and human macrophages in response to LPS , suggesting the existence of an autocrine pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c201 : 1
m89*0.1
nodelay
--
0
PMID: 17456803,9761426 In vitro stimulation of murine peritoneal macrophages with ET-1 induced cyclooxygenase 2 (COX-2) mRNA expression and PGE2 production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
m89*0.1
nodelay
--
0
PMID: 17456803,9761426 In vitro stimulation of murine peritoneal macrophages with ET-1 induced cyclooxygenase 2 (COX-2) mRNA expression and PGE2 production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c204 : 1
stoichiometry:c206 : 1
stoichiometry:c205 : 1
m89*m41*0.1
nodelay
--
0
PMID: 17456803,9201047 In human monocytes, ET-1 triggered TNF production, as well as other cytokines, including IL-8, GM-CSF, IL-1beta, and IL-6
p31
p76
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c207 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m89*m82*0.1
nodelay
--
0
PMID: 17456803,9201047 In human monocytes, ET-1 triggered TNF production, as well as other cytokines, including IL-8, GM-CSF, IL-1beta, and IL-6
p31
p77
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c211 : 1
m93248*m89*0.1
nodelay
--
0
PMID: 17456803,9201047 In human monocytes, ET-1 triggered TNF production, as well as other cytokines, including IL-8, GM-CSF, IL-1beta, and IL-6
p31
p78
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c214 : 1
stoichiometry:c215 : 1
m89*m93364*0.1
nodelay
--
0
PMID: 17456803,9201047 In human monocytes, ET-1 triggered TNF production, as well as other cytokines, including IL-8, GM-CSF, IL-1beta, and IL-6
p31
p79
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c216 : 1
stoichiometry:c218 : 1
stoichiometry:c217 : 1
m92*m89*0.1
nodelay
--
0
PMID: 17456803,9201047 In human monocytes, ET-1 triggered TNF production, as well as other cytokines, including IL-8, GM-CSF, IL-1beta, and IL-6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m1965*0.1
nodelay
--
0
PMID: 17456803,11777907,10770944,15498833 This phosphorylation promotes translocation of the cytosolic adaptor arrestin proteins to the membrane, where they bind to the receptor and promote internalization through interaction with Beta2-adaptin and clathrin components of the endocytic machinery
p80
p80
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c219 : 1
stoichiometry:c220 : 1
stoichiometry:c221 : 1
m93*m41*0.1
nodelay
--
0
PMID: 17456803,9444616 For example, ET-1 treatment of the macrophage cell line J774.2 increased TNF secretion via the ETAR
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c224 : 1
stoichiometry:c223 : 1
m95*m89*0.1
nodelay
--
0
PMID: 17456803,15059899 Finally, ET-1, as well as ET-2, elicited MMP-2 and -9 production from human monocyte-derived macrophages when cocultured with breast cancer cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c225 : 1
stoichiometry:c227 : 1
m95*m94*0.1
nodelay
--
0
PMID: 17456803,15059899 Finally, ET-1, as well as ET-2, elicited MMP-2 and -9 production from human monocyte-derived macrophages when cocultured with breast cancer cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c229 : 1
stoichiometry:c230 : 1
m89*m96*0.1
nodelay
--
0
PMID: 17456803,15059899 Finally, ET-1, as well as ET-2, elicited MMP-2 and -9 production from human monocyte-derived macrophages when cocultured with breast cancer cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c231 : 1
stoichiometry:c232 : 1
stoichiometry:c233 : 1
m94*m96*0.1
nodelay
--
0
PMID: 17456803,15059899 Finally, ET-1, as well as ET-2, elicited MMP-2 and -9 production from human monocyte-derived macrophages when cocultured with breast cancer cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c235 : 1
m89*0.1
nodelay
--
0
PMID: 17456803,8825394 ET-1 can also influence the production of superoxides by macrophages; ET-1 primed O2? production from rabbit alveolar macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c237 : 1
m89*0.1
nodelay
--
0
PMID: 17456803,8825394 ET-1 can also influence the production of superoxides by macrophages; ET-1 primed O2? production from rabbit alveolar macrophages
p87
p87
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c240 : 1
stoichiometry:c239 : 1
m155666*m99*0.1
nodelay
--
0
PMID: 17456803,10338485,10534342,7693362 PAF antagonists inhibited LPS-regulated iNOS mRNA expression and NO production in murine macrophages and rat Kupffer cells, implying an involvement of autocrine PAF in LPS responses
p88
p88
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c242 : 1
stoichiometry:c243 : 1
m100*m5783*0.1
nodelay
--
0
PMID: 17456803,15718414,12117933 Exogenous LTB4 activated the NADPH oxidase system in alveolar macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages
p88
p89
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c244 : 1
stoichiometry:c245 : 1
stoichiometry:c246 : 1
m101*m5783*0.1
nodelay
--
0
PMID: 17456803,15718414,12117933 Exogenous LTB4 activated the NADPH oxidase system in alveolar macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m1966*0.1
nodelay
--
0
PMID: 17456803,11777907,10770944,15498833 This phosphorylation promotes translocation of the cytosolic adaptor arrestin proteins to the membrane, where they bind to the receptor and promote internalization through interaction with Beta2-adaptin and clathrin components of the endocytic machinery
p90
p90
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c248 : 1
stoichiometry:c249 : 1
m100*m41*0.1
nodelay
--
0
PMID: 17456803,15718414,12117933 Exogenous LTB4 activated the NADPH oxidase system in alveolar macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages
p90
p91
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c250 : 1
stoichiometry:c251 : 1
stoichiometry:c252 : 1
m101*m41*0.1
nodelay
--
0
PMID: 17456803,15718414,12117933 Exogenous LTB4 activated the NADPH oxidase system in alveolar macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c253 : 1
stoichiometry:c254 : 1
stoichiometry:c255 : 1
m93479*m100*0.1
nodelay
--
0
PMID: 17456803,15718414,12117933 Exogenous LTB4 activated the NADPH oxidase system in alveolar macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c256 : 1
stoichiometry:c258 : 1
stoichiometry:c257 : 1
m93479*m101*0.1
nodelay
--
0
PMID: 17456803,15718414,12117933 Exogenous LTB4 activated the NADPH oxidase system in alveolar macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages , as well as NO and TNF production and parasite killing in Trypanosoma cruzi-infected murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c259 : 1
stoichiometry:c261 : 1
stoichiometry:c260 : 1
m103*0.1
nodelay
--
0
PMID: 17456803,7836930,11301049 In fact, the effects are selective; PGE2 inhibited the production of the Th1-promoting cytokine IL-12 but amplified IL-10 production from human and mouse macrophages respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c262 : 1
stoichiometry:c264 : 1
stoichiometry:c263 : 1
m39*m104*0.1
nodelay
--
0
PMID: 17456803,7836930,11301049 In fact, the effects are selective; PGE2 inhibited the production of the Th1-promoting cytokine IL-12 but amplified IL-10 production from human and mouse macrophages respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c265 : 1
stoichiometry:c267 : 1
stoichiometry:c266 : 1
m105*0.1
nodelay
--
0
PMID: 17456803,11160207 Similarly, Kuroda et al. showed that pretreatment of murine splenocytes with PGE2 suppressed the protein expression of the Th1-associated chemokine IFN-inducible protein-10 and enhanced production of macrophage-derived chemokine/CCL22, a ligand for the Th2 cell-expressed chemokine receptor CCR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c269 : 1
stoichiometry:c270 : 1
stoichiometry:c268 : 1
m106*m39*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c271 : 1
stoichiometry:c272 : 1
stoichiometry:c273 : 1
m4465*m107*0.1
nodelay
--
0
PMID: 17456803,11160207 Similarly, Kuroda et al. showed that pretreatment of murine splenocytes with PGE2 suppressed the protein expression of the Th1-associated chemokine IFN-inducible protein-10 and enhanced production of macrophage-derived chemokine/CCL22, a ligand for the Th2 cell-expressed chemokine receptor CCR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c274 : 1
stoichiometry:c275 : 1
stoichiometry:c276 : 1
m38875*m111*0.1
nodelay
--
0
PMID: 17456803,12829604 In humans, EMR2 and CD97 were identified as receptors for cell surface chondroitin sulfate , suggesting that the ligand for EMR1 may be a proteoglycan.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--